AB 1963 – CaliforniaStatus: Inactive / Dead
Year Introduced: 2018
Medi-Cal: reimbursement: opioid addiction treatment: This bill would require the department to increase the Medi-Cal provider reimbursement rates, as specified, for medication-assisted treatments, buprenorphine/naloxone combination treatment, methadone treatment, and naltrexone treatment, provided by certified providers, for opioid addiction.
Return to Database Search
© 2018-2019 The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.